BENDEKA J Code: J9034

Drug & Product Overview

HCPCS Descriptor Injection, bendamustine hcl (bendeka), 1 mg

HCPCS Added Date January 1, 2017

Manufacturer Teva

Route of Administration Intravenous

Generic Status Single-Source; Branded

Dosage Type Multi-Dose

Dosage Form Injection, Solution

About BENDEKA

Bendeka is a medication aligned to the HCPCS J Code: J9034 for billing, pricing, and reimbursement purposes in the United States. It is an Oncology drug administered via the intravenous route and manufactured by Teva.

According to CMS Drug Use Information: This medication is used to treat certain types of cancer. Bendamustine belongs to a class of cancer chemotherapy drugs known as alkylating agents. It works by killing cancer cells or slowing their growth.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
63459-0348-04	Bendeka	Teva Pharmaceuticals USA, Inc.	100	100 MG / 4 ML

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

BENDEKA Pricing & Reimbursement

J9034 Private Payer Reimbursement

$13.30 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q3 2026

Bendamustine Hydrochloride 505(b)(2) Information:

HCPCS Code	Manufacturer	Active Ingredient	HCPCS Description
J9033	Generic Code (Multiple Manufacturers)	Bendamustine Hydrochloride	Injection, bendamustine hydrochloride, not otherwise specified, 1 mg
J9034	Teva	Bendamustine Hydrochloride	Injection, bendamustine hcl (bendeka), 1 mg
J9036	Generic Code (Multiple Manufacturers)	Bendamustine Hydrochloride	Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg
J9056	Generic Code (Multiple Manufacturers)	Bendamustine Hydrochloride	Injection, bendamustine hydrochloride (vivimusta), 1 mg

BENDEKA Claims Performance

Claims from Jan 2026 – Aug 2026

Claim Denial Rate 8.95%

Avg. Days to File 8.6days

Avg. Days to Pay 25.1days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J9034 claims analytics on FocalPoint →

BENDEKA CPT Administration Codes

CPT Code	Description
96413	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415	Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)

Not on the CMS JW / JZ list

CMS does not include Bendeka (J9034) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9034. Wastage billing guide →

BENDEKA Medically Unlikely Edits (MUE)

The most billing units of J9034 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.

Practitioner Office & Hospital Outpatient

360 units / day

= 360 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

BENDEKA Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Chronic Lymphocytic Leukemia Non-Hodgkin Lymphoma

Drug Class

Alkylating Activity [MoA]Alkylating Drug [EPC]

Frequently Asked Questions

Is there an available Bendeka billing and coding guide?

Our team has not identified a manufacturer-published source of billing and coding information for BENDEKA.

Are there any available Bendeka patient assistance programs?

Our team has not identified a manufacturer-published source of patient assistance information for BENDEKA.

Where can I find Bendeka prescribing information?

BENDEKA prescribing information can be found at the link below: Visit Here →

Where can I find Bendeka side effect information?

Information regarding BENDEKA's side effects can be found at MedlinePlus Visit Here →

Does billing BENDEKA require JZ/JW wastage modifiers?

CMS does not include BENDEKA (J9034) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9034. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.